Evidence map›Paper›PMID 32725303›Full record

ArticleMycorrhiza2020

Soil legacy determines arbuscular mycorrhizal spore bank and plant performance in the low Arctic.

Minna-Maarit Kytöviita, Mauritz Vestberg

Open access · hybridAbstract read
In one paragraph

Article in Mycorrhiza, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Minna-Maarit KytöviitaDepartment of Biological and Environmental Science, University of Jyvaskyla, 40014, Jyvaskyla, Finland. minna-maarit.kytoviita@jyu.fi.ORCID https://orcid.org/0000-0002-8928-6951
Mauritz VestbergNatural Resources Institute Finland (Luke), Helsinki, Finland.
Natural Resources Institute Finland · FIUniversity of Jyväskylä · FI

Funding

Academy of Finland 203816, 287545
6 · The paper itself

Abstract

Human impact is rapidly changing vegetation globally. The effect of plant cover that no longer exists in a site may still affect the development of future vegetation. We focused on a little studied factor-arbuscular mycorrhizal (AM) fungus spore bank-and its effect on three test plant species. In a low Arctic field site, plots were maintained for 6 years, devoid of any vegetation or with a Solidago virgaurea monoculture cover. We analysed the AM fungal morphospecies composition and identified 21 morphospecies in the field plots. The AM morphospecies community was dominated by members of Acaulosporaceae. Monoculturing under low Arctic field conditions changed the soil AM spore community, which became dominated by Glomus hoi. We tested the soil feedback in the greenhouse and grew Solidago virgaurea, Potentilla crantzii and Anthoxanthum odoratum in the field soils from the plots without plant cover, covered with Solidago virgaurea or with intact vegetation. Our results suggest that monoculturing resulted in improved N acquisition by the monocultured plant species Solidago virgaurea which may be related to the AM fungus community. Our results show that a rich community of AM fungus spores may remain viable under field conditions for 6 years in the low Arctic. Spore longevity in field soil in the absence of any host plants differed among AM fungus species. We suggest that AM fungus spore longevity be considered an AM fungal life-history trait.

Indexed as

MycorrhizaeSolidagoArctic RegionsHumansPlant RootsSoilSoil MicrobiologySoilAcaulosporaceaeAM spore bankMonoculturingSolidago virgaurea

Identifiers

PMID32725303
PMCPMC7410866
OpenAlexW3045608079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.